# Top 50 Medical VC (Venture Capital) Funds in China in June 2026

## BioVenture
- Type: VC Fund
- Location: Suzhou, Jiangsu, China
- Relevant deals: 38
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Biotechnology

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

## HSG
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 34
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Software

We help founders build enduring companies.

## Qiming Venture Partners
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 31
- Stages: Series B, Series A, Series C
- Focus: Health Care, Biotechnology, Medical

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

## Med-Fine Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 27
- Stages: Series A, Seed, Series B
- Focus: Medical, Health Care, Biotechnology

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

## Legend Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 24
- Stages: Series B, Series A, Series C
- Focus: Health Care, Medical, Biotechnology

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

## Frees Fund
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 20
- Stages: Series A, Seed, Angel
- Focus: Artificial Intelligence, Health Care, Biotechnology

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

## Marathon Venture Partners
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 20
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Biotechnology

Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.

## Cowin Venture
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 20
- Stages: Series A, Angel, Series B
- Focus: Health Care, Medical, Biotechnology

Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.

## Shanghai Biomedical Industrial Equity Investment Fund
- Type: VC Fund
- Location: Huangpu, Shanghai, China
- Relevant deals: 20
- Stages: Series A, Seed, Series B
- Focus: Health Care, Medical, Biotechnology

Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry.

## Puhua Capital
- Type: VC Fund
- Location: Hangzhou, Zhejiang, China
- Relevant deals: 19
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Manufacturing

Puhua Capital is an equity investment firm that focuses on early and middle project.

Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

## Lilly Asia Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 18
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto. 

## IDG Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 17
- Stages: Series A, Series B, Series C
- Focus: Software, Internet, E-Commerce

IDG Capital is a global investment firm partnering with founders to build enduring businesses through capital, expertise, and long-term support.

## Matrix Partners China
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 16
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Software

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

## Highlight Capital
- Type: VC Fund
- Location: Nanjin, Jiangsu, China
- Relevant deals: 16
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Biotechnology

Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.

## Prox Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 16
- Stages: Seed, Series A
- Focus: Medical, Biotechnology, Health Care

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

## Dalton Venture
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 15
- Stages: Seed, Series A, Series B
- Focus: Health Care, Medical, Biotechnology

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

## Legend Star
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 15
- Stages: Series A, Seed, Angel
- Focus: Health Care, Medical, Biotechnology

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

## Northern Light Venture Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 15
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Biotechnology

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

## BioTrack Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 15
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Medical

BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.

## ZSVC
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 15
- Stages: Series A, Seed, Series B
- Focus: Manufacturing, Medical, Health Care

ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.

## Share Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 15
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Biotechnology

Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.

## Haiyuan Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 14
- Stages: Series A, Seed, Angel
- Focus: Manufacturing, Medical, Semiconductor

Goldport Capital is a Shenzhen-based asset management company.

## Cowin Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 14
- Stages: Series A, Series B, Seed
- Focus: Manufacturing, Health Care, Biotechnology

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.

## CDH Investments
- Type: VC Fund
- Location: Kowloon City, Kowloon, Hong Kong
- Relevant deals: 14
- Stages: Series A, Series B, Series C
- Focus: Manufacturing, Health Care, Biotechnology

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

## Longpan Investment
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 13
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Biotechnology

Longpan Investment is an investment firm.

## Taiyu Investment
- Type: VC Fund
- Relevant deals: 13
- Stages: Seed, Series A, Angel
- Focus: Medical, Health Care, Biotechnology

Taiyu Investment is an investment firm.

## Shenzhen Capital Group
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 13
- Stages: Series A, Series B, Series C
- Focus: Manufacturing, Health Care, Software

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB.
SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

## Sherpa Healthcare Partners
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 12
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships,  as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

## Oriza Seed Capital (Oriza Yuandian)
- Type: VC Fund
- Location: Suzhou, Jiangsu, China
- Relevant deals: 12
- Stages: Series A, Seed, Angel
- Focus: Manufacturing, Health Care, Medical

Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.

## Cenova
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 12
- Stages: Series B, Series A, Series C
- Focus: Medical, Health Care, Biotechnology

Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.

## Lenovo Capital and Incubator Group (LCIG)
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 11
- Stages: Series A, Seed, Series B
- Focus: Manufacturing, Artificial Intelligence, Software

Lenovo Capital and Incubator Group is an accelerator and venture capital firm.

## Sunland Fund
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 11
- Stages: Series B, Series A, Seed
- Focus: Medical, Health Care, Medical Device

Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

## Shunwei Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 10
- Stages: Series A, Series B, Series C
- Focus: Manufacturing, Software, Internet

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.

## Long Hill Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 10
- Stages: Series A, Series B, Series C
- Focus: Medical, Health Care, Training

Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates(NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor.Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.

## EFung Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 10
- Stages: Series B, Series A, Series C
- Focus: Health Care, Biotechnology, Medical

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

## Pan-Lin Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 10
- Stages: Seed, Series A, Series B
- Focus: Health Care, Biotechnology, Medical

Panlin Capital, following the investment theme of ‘consumption upgrade driven by  technology innovation’, targets the start-ups which are specialized in biotechnology and data intelligence sectors.As a venture capital corporation, Panlin Capital has became professional as well as influential in the biotechnology and data intelligence sectors.Identify the entrepreneurs among scientists.Enable the innovators among entrepreneurs。

## Trustbridge Partners
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 9
- Stages: Series A, Series B, Series C
- Focus: Education, Health Care, Medical

Trustbridge Partners is a mission-driven growth equity firm founded in 2006 with approximately $8 billion under management.

## Lotus Lake Ventures
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 9
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Biotechnology

Lotus Lake Ventures is an investment firm committed to investing in science and technology innovation enterprises, focusing on high-tech and high-tech enterprises with core competitiveness in the initial stage and growth stage..

## Green Pine Capital Partners
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 9
- Stages: Series A, Series B, Angel
- Focus: Software, Biotechnology, Manufacturing

Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into  388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China.

## Kaitai Capital
- Type: VC Fund
- Location: Hangzhou, Zhejiang, China
- Relevant deals: 9
- Stages: Series A, Series B, Angel
- Focus: Biotechnology, Health Care, Pharmaceutical

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

## Gaorong Capital
- Type: VC Fund
- Location: Wangjing, Beijing, China
- Relevant deals: 9
- Stages: Series A, Series B, Seed
- Focus: Information Technology, Software, Artificial Intelligence

Gaorong Capital is a venture capital firm that focuses on early and growth stage investments in TMT, including AI and frontier technologies.

## CD Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 9
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Medical Device

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

## Hillhouse Investment
- Type: VC Fund
- Location: Changyang, Beijing, China
- Relevant deals: 9
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Software

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

## Addor Capital
- Type: VC Fund
- Location: Nanjing, Jiangsu, China
- Relevant deals: 9
- Stages: Series A, Series B
- Focus: Manufacturing, Semiconductor, Electronics

Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.

## Fortune Venture Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 9
- Stages: Series A, Series B, Seed
- Focus: Manufacturing, Software, Information Technology

Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.

## BIOCHING CAPITAL
- Type: VC Fund
- Location: Longgang, Guangdong, China
- Relevant deals: 9
- Stages: Angel, Series A, Seed
- Focus: Medical, Medical Device, Biotechnology

BIOCHING CAPITAL is an investment management firm.

## Huagai Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 9
- Stages: Series A, Series B, Angel
- Focus: Health Care, Biotechnology, Medical

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

## Haibang Capital
- Type: VC Fund
- Location: Hangzhou, Zhejiang, China
- Relevant deals: 9
- Stages: Series A, Angel, Series B
- Focus: Health Care, Biotechnology, Manufacturing

Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.

## Oriental Fortune Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 8
- Stages: Series A, Series B, Seed
- Focus: Software, Manufacturing, Information Technology

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

## SBCVC
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 8
- Stages: Series B, Series A, Series C
- Focus: Health Care, Software, Medical

Established in 2000, SB China Capital (SBCVC) is a leading venture capital and private equity firm that manages both USD and RMB funds. Their investment focuses on high-tech, high growth companies in TMT, clean technology, healthcare, consumer/retail, and advanced manufacturing sectors; and they invest across all stages of companies.Withextensive entrepreneurial and operating experiences, their professional and seasoned deal team members recognize the vision and champion the ideas of start-up companies. In addition to providing capital support, they help their portfolio companies realize their strategic and commercial potential by giving value-adding services and advices including planning, business development, recruiting and resources deployment.They have a proven track record and solid reputation in identifying high potential start-ups and creating successful industry-leading companies. Some of their spotlight portfolio companies are Alibaba, Taobao, Focus Media, GDS, BGI, Ankon, Di’an, and Edan.With their operational headquarters located in Shanghai and regional offices spread in Beijing, Shenzhen, Chengdu, Hangzhou and Taiwan, they have an extensive coverage of the greater China region and access to potential investment opportunities.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co